What are the grades of paronychia and the recommended treatment for each grade?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Paronychia Grading and Treatment

Paronychia is graded using the CTCAE v5.0 system (Grades 0-3), with treatment escalating from topical therapies for mild disease to surgical intervention for severe cases, while continuing cancer therapy at current doses for Grades 1-2. 1

Grading System (CTCAE v5.0)

Grade 0 (Prevention)

  • No active disease
  • Focus on preventive measures to avoid development

Grade 1: Mild Disease

  • Clinical features: Nail fold edema or erythema; disruption of the cuticle
  • Functional impact: None
  • Treatment approach: Continue cancer drug at current dose and monitor 1

Grade 2: Moderate Disease

  • Clinical features: Nail fold edema or erythema with pain; discharge present or nail plate separation occurring
  • Functional impact: Limits instrumental activities of daily living (ADLs)
  • Treatment approach: Continue cancer drug at current dose; obtain cultures if infection suspected 1

Grade 3: Severe Disease

  • Clinical features: Surgical intervention or antibiotics indicated
  • Functional impact: Limits self-care ADLs
  • Treatment approach: Interrupt cancer therapy until Grade 0-1 achieved; obtain cultures if infection suspected 1

Treatment Algorithm by Grade

Grade 0 (Prevention)

Implement protective measures 1:

  • Wear comfortable, well-fitting shoes and cotton socks
  • Use gloves while cleaning
  • Avoid cutting nails too short or biting nails
  • Preventive correction of nail curvature (podiatry referral if needed)
  • Avoid repeated friction, trauma, and excessive pressure
  • Daily antimicrobial soaks and cleansing with water
  • Apply topical emollients to cuticles and periungual tissues daily
  • Biotin supplementation to improve nail strength

Grade 1 Treatment

Primary therapy 1:

  • Topical povidone-iodine 2% twice daily (evidence-based benefit) 2
  • Topical antibiotics/corticosteroids combination
  • Continue all preventive measures

Reassess after 2 weeks: If worsening or no improvement, escalate to Grade 2 treatment 1

Grade 2 Treatment

Escalated therapy 1:

  • Topical povidone-iodine 2% twice daily
  • AND/OR topical beta-blocking agents (timolol 0.5% gel twice daily under occlusion) 1, 3
  • AND/OR topical antibiotics plus corticosteroids
  • AND/OR oral antibiotics
  • Obtain bacterial/viral/fungal cultures if infection suspected

Key consideration: Secondary bacterial or mycological superinfections occur in up to 25% of cases 1

Reassess after 2 weeks: If worsening or no improvement, escalate to Grade 3 treatment 1

Grade 3 (or Intolerable Grade 2) Treatment

Aggressive intervention required 1:

  • Interrupt cancer therapy until Grade 0-1
  • Obtain bacterial/viral/fungal cultures
  • Continue topical povidone-iodine 2%/topical beta-blockers/topical antibiotics and corticosteroids
  • AND/OR oral antibiotics
  • OR consider partial nail avulsion

Additional surgical options for pyogenic granuloma 4, 1:

  • Scoop shave removal plus hyfrecation
  • Silver nitrate cauterization
  • Cryotherapy
  • Acrylic treatment with gutter splint for onychocryptosis

Reassess after 2 weeks: If no improvement, dose interruption or discontinuation of cancer therapy may be necessary 1

Special Considerations for Drug-Induced Paronychia

Recurrent, Severe, or Treatment-Refractory Cases 4

  • Doxycycline 100 mg twice daily
  • Intralesional triamcinolone acetonide for persistent inflammation
  • Combination topical therapy with antibiotics and corticosteroids
  • Follow-up after 1 month

Management of Onychocryptosis (Ingrown Nail) 4

  • Dental floss nail splinting: Insert under ingrown nail to separate lateral edge from underlying tissue
  • Flexible tube splinting: Place plastic tube with lengthwise incision on lateral nail edge
  • Cotton packing/cast edge separation
  • Formable acrylic for fixation of splint and nail prosthesis

Critical Pitfalls to Avoid

  1. Don't delay culture collection: Up to 25% have secondary infections with both gram-positive and gram-negative organisms 1

  2. Don't continue cancer therapy at Grade 3: Drug interruption is mandatory until improvement to Grade 0-1 1

  3. Don't use topical steroids alone if pus present: Stop steroids and treat infection first 4

  4. Don't overlook the great toes and thumbs: These are most frequently affected due to repeated trauma 1

  5. Monitor for progression to pyogenic granuloma: Friable granulation tissue on lateral nail folds mimics ingrown nails and requires more aggressive treatment 1

Evidence Quality Note

The ESMO 2021 guidelines 1 provide the most comprehensive and recent evidence-based framework, with Level III evidence and Grade B recommendations for most interventions. The 2022 targeted therapy guidelines 4 complement this with specific algorithms for cancer patients. Topical povidone-iodine 2% has the strongest controlled study evidence 2, while topical timolol shows promising results in case series 1, 3.

References

Related Questions

When is incision and drainage indicated for a paronychia?
In an adult with acute paronychia who refuses incision and drainage, how should cefadroxil be used?
What is the likely cause of a painful clear fluid collection around the fingernail (acute paronychia) and how should it be treated?
In acute paronychia, should treatment be with oral antibiotics or topical antibiotics?
How should acute and chronic paronychia be managed, including first-line treatments, appropriate antibiotic selection, and indications for incision and drainage?
In an adult with acute paronychia who refuses incision and drainage, how should cefadroxil be used?
In a male patient on high‑dose statin therapy who has symptoms of low testosterone, should the statin be continued and how should testosterone be evaluated and managed?
If the only antiseptic available is 10% povidone‑iodine, should it be diluted to a 2% solution, and how should the dilution be prepared?
What is the relationship between vitamin B12 deficiency and elevated homocysteine levels?
In a patient with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis who has low immunoglobulin A (IgA) and immunoglobulin M (IgM) but normal immunoglobulin G (IgG), how long should I wait before the next rituximab infusion?
What is the best scoring tool to determine whether a patient should undergo a stress test versus left‑heart catheterization?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.